Intellia Therapeutics (NTLA) Revenue (2015 - 2026)
Intellia Therapeutics' Revenue was $7.66 million in Q2 2026, down 46.2% from $14.25 million a year earlier and down 49.1% from the prior quarter.
Powered by 
Analysis
Intellia Therapeutics (NTLA) Revenue (2015 - 2026) Analysis & Trends
On a trailing twelve-month basis, Intellia Therapeutics' Revenue was $59.51 million through Jun 30, 2026, up 12.6% year-over-year; for FY2025, it came in at $67.67 million, up 16.9% from FY2024.
- Revenue shows a five-year compound annual growth rate of 3.1% (FY2020 to FY2025).
- In earlier years, Revenue was $57.88 million in FY2024 (+59.6%), $36.28 million in FY2023 (-30.4%), $52.12 million in FY2022 (+57.7%) and $33.05 million in FY2021 (-43.0%).
- The Q2 2026 figure marks the lowest quarterly Revenue since Q2 2024.
- Compared with a year earlier, Revenue was higher in three of the last seven quarters, with growth averaging 16.1%.
- The best year-over-year quarter for Revenue over five years was Q1 2024 (growth of 129.5%); the worst was Q3 2021 (a decline of 67.6%).
- Per Business Quant data, NTLA's Revenue in the three quarters before Q2 2026 was $15.05 million (Q1 2026), $23.02 million (Q4 2025) and $13.78 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Intellia Therapeutics | 1.60 Bn | 1.60 Bn | - | 7.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.66 Mn |
| Mar 31, 2026 | 15.05 Mn |
| Dec 31, 2025 | 23.02 Mn |
| Sep 30, 2025 | 13.78 Mn |
| Jun 30, 2025 | 14.25 Mn |
| Mar 31, 2025 | 16.63 Mn |
| Dec 31, 2024 | 12.87 Mn |
| Sep 30, 2024 | 9.11 Mn |
| Jun 30, 2024 | 6.96 Mn |
| Mar 31, 2024 | 28.94 Mn |
| Dec 31, 2023 | -1.92 Mn |
| Sep 30, 2023 | 11.99 Mn |
| Jun 30, 2023 | 13.59 Mn |
| Mar 31, 2023 | 12.61 Mn |
| Dec 31, 2022 | 13.57 Mn |
| Sep 30, 2022 | 13.27 Mn |
| Jun 30, 2022 | 14.03 Mn |
| Mar 31, 2022 | 11.25 Mn |
| Dec 31, 2021 | 12.85 Mn |
| Sep 30, 2021 | 7.20 Mn |
API Access
Intellia Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=NTLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "NTLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=NTLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();